PhD Candidate in Tumor Biology

NTNU is a broad-based university with a technical-scientific profile and a focus in professional education. The university is located in three cities with headquarters in Trondheim.

At NTNU, 9,000 employees and 42,000 students work to create knowledge for a better world.

You will find more information about working at NTNU and the application process here.

(Video unable to load from YouTube. Accept cookie and refresh page to watch video, or click here to open video)

We have a vacancy for a 100 % position as PhD candidate in the fields of computational and experimental tumor biology, which is available from the Autumn of 2022.

Research at the Department of Biomedical Laboratory Science focuses on cancer, including cellular and molecular mechanisms as well as personalized diagnosis and treatment of cancer. We collaborate closely with basic researchers and clinicians at NTNU and St. Olav’s University Hospital in Trondheim. Our overall goal is to improve diagnostics and treatment for the benefit of patients and next-of-kin. We have access to relevant infrastructures for experimental and translational research with state-of-the-art equipment, as well as to core facilities in imaging, bioinformatics, genomics, and proteomics.

In the position as a PhD candidate, your main goal is a completed doctoral education up to an obtained doctoral degree. The purpose of your PhD research is to develop a computational-experimental approach to understand and target cancer pathways and tumor microenvironment communication primarily in epithelial ovarian cancer. You will be part of the Cancer-Stroma Crosstalk research group (https://www.ntnu.edu/ibf/research/cancer-stroma# ) led by Professor Kaisa Lehti. Initial data analysis will focus on group’s preliminary datasets linking tumor extracellular matrix pathways to cancer cell metabolic traits and therapy response. Your study will be jointly supervised by Kaisa Lehti (experimental, Department of Biomedical Laboratory Science), Martin Kuiper (computational, Department of Biology) and Åsmund Flobak (computational to translational, Department of Clinical and Molecular Medicine).

Your immediate leader is Professor Kaisa Lehti.